Fifth Third Bancorp’s CRISPR Therapeutics CRSP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $730 | Sell |
15
-5
| -25% | -$243 | ﹤0.01% | 2462 |
|
2025
Q1 | $681 | Buy |
+20
| New | +$681 | ﹤0.01% | 2428 |
|
2024
Q4 | – | Sell |
-250
| Closed | -$11.7K | – | 2533 |
|
2024
Q3 | $11.7K | Hold |
250
| – | – | ﹤0.01% | 1942 |
|
2024
Q2 | $13.5K | Hold |
250
| – | – | ﹤0.01% | 1839 |
|
2024
Q1 | $17K | Sell |
250
-125
| -33% | -$8.52K | ﹤0.01% | 1699 |
|
2023
Q4 | $23.5K | Hold |
375
| – | – | ﹤0.01% | 1721 |
|
2023
Q3 | $17K | Sell |
375
-350
| -48% | -$15.9K | ﹤0.01% | 1795 |
|
2023
Q2 | $40.7K | Hold |
725
| – | – | ﹤0.01% | 1450 |
|
2023
Q1 | $32.8K | Hold |
725
| – | – | ﹤0.01% | 1619 |
|
2022
Q4 | $29.5K | Hold |
725
| – | – | ﹤0.01% | 1560 |
|
2022
Q3 | $47K | Hold |
725
| – | – | ﹤0.01% | 1335 |
|
2022
Q2 | $44K | Buy |
725
+125
| +21% | +$7.59K | ﹤0.01% | 1409 |
|
2022
Q1 | $38K | Sell |
600
-1,050
| -64% | -$66.5K | ﹤0.01% | 1560 |
|
2021
Q4 | $125K | Buy |
1,650
+500
| +43% | +$37.9K | ﹤0.01% | 1164 |
|
2021
Q3 | $129K | Buy |
1,150
+450
| +64% | +$50.5K | ﹤0.01% | 1103 |
|
2021
Q2 | $113K | Hold |
700
| – | – | ﹤0.01% | 1151 |
|
2021
Q1 | $85K | Hold |
700
| – | – | ﹤0.01% | 1205 |
|
2020
Q4 | $107K | Hold |
700
| – | – | ﹤0.01% | 1132 |
|
2020
Q3 | $59K | Hold |
700
| – | – | ﹤0.01% | 1276 |
|
2020
Q2 | $51K | Buy |
700
+250
| +56% | +$18.2K | ﹤0.01% | 1299 |
|
2020
Q1 | $19K | Buy |
450
+350
| +350% | +$14.8K | ﹤0.01% | 1539 |
|
2019
Q4 | $6K | Hold |
100
| – | – | ﹤0.01% | 1925 |
|
2019
Q3 | $4K | Hold |
100
| – | – | ﹤0.01% | 1951 |
|
2019
Q2 | $5K | Hold |
100
| – | – | ﹤0.01% | 1989 |
|
2019
Q1 | $4K | Hold |
100
| – | – | ﹤0.01% | 1960 |
|
2018
Q4 | $3K | Hold |
100
| – | – | ﹤0.01% | 2047 |
|
2018
Q3 | $4K | Buy |
100
+20
| +25% | +$800 | ﹤0.01% | 2011 |
|
2018
Q2 | $5K | Buy |
+80
| New | +$5K | ﹤0.01% | 2037 |
|